Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX

7 Apr 2017

7 Apr 2017: EVVIVAX Visiting PennVet, Philadelphia, USA

Dr Luigi Aurisicchio, CEO at EVVIVAX and President at VITARES, is very happy to visit the School of Veterinary Medicine at the

University of Pennsylvania (PennVet). This can be a great opportunity of collaboration in the field of Cancer Vaccines and their application for Pets, looking at a near-future in Human Immuno-Oncology.

PennVet

PennVet was founded in 1884, and has a long-standing tradition as a global leader in veterinary medicine education, research, and clinical care, with a tradition of compassionate clinical expertise, intellectual rigor and the pursuit of innovative thinking.

Penn Vet is a member of the One Health Initiative, a movement to forge co-equal, all-inclusive collaborations between physicians, veterinarians, dentists, nurses, and other scientific and environmentally related disciplines. These principles are in line with VITARES Initiative.

For more info: http://www.vet.upenn.edu/about/who-we-are

Evvivax News